Hjem › Brystkreft › Maryland › Columbia
Kliniske studier for Brystkreft i Columbia, MD
15 studier for Brystkreft søker deltakere på steder i og rundt Columbia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Northwest Hospital Center, Randallstown · 9 mi unna
- William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster · 25 mi unna
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RekruttererFase 2
- Maryland Oncology Hematology, Laurel · 10 mi unna
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Columbia
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruttererFase 3
- Clinical Trial Site, Catonsville · 6 mi unna
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruttererFase 3
- Maryland Oncology Hematology P.A., Columbia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Maryland Oncology Hematology, P.A., Columbia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Northwest Hospital Center, Randallstown · 9 mi unna
E-Mindfulness Approaches for Living After Breast Cancer
RekruttererFase 3
- Central Maryland Radiation Oncology in Howard County, Columbia
Integrated Cancer Repository for Cancer Research
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Northwest Hospital, Randallstown · 9 mi unna
- William E. Kahlert Regional Cancer Center, Westminster · 25 mi unna
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Maryland Oncology Hematology P.A., Columbia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Central Maryland Radiation Oncology in Howard County, Columbia
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
RekruttererFase 2
- Maryland Oncology Hematology, Columbia
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster · 25 mi unna
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
Rekrutterer
- Central Maryland Oncology Center, Columbia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruttererObservasjonsstudie
- Maryland Oncology Hematology, PA, Columbia
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Columbia
- Lungekreft7 studier
- Ikke-småcellet lungekreft6 studier
- Overvekt6 studier
- Prostatakreft6 studier
- Fedme5 studier
- Metastatisk kreft5 studier
- Blærekreft5 studier
- Kolorektal kreft5 studier
- Melanom4 studier
- Pankreaskreft4 studier
- Tykktarmskreft4 studier
- Endometriekreft3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.